L2 Asset Management LLC Takes $1.36 Million Position in Chemed Corporation $CHE

L2 Asset Management LLC bought a new position in Chemed Corporation (NYSE:CHE) during the 2nd quarter, Holdings Channel reports. The fund bought 2,911 shares of the company’s stock, valued at approximately $1,356,000.

A number of other hedge funds also recently bought and sold shares of CHE. Northwestern Mutual Wealth Management Co. raised its position in Chemed by 2,444,879.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after purchasing an additional 5,549,876 shares during the period. BlackRock Inc. purchased a new stake in shares of Chemed in the second quarter worth approximately $691,290,000. Norges Bank bought a new stake in shares of Chemed during the 4th quarter worth approximately $76,067,000. AQR Capital Management LLC boosted its holdings in Chemed by 89.2% during the 4th quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after acquiring an additional 153,469 shares during the period. Finally, Victory Capital Management Inc. grew its position in Chemed by 1,260.2% in the 4th quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock valued at $50,353,000 after acquiring an additional 109,033 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Trading Down 0.1%

Shares of NYSE CHE opened at $540.18 on Tuesday. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17. The business has a fifty day simple moving average of $501.57 and a two-hundred day simple moving average of $447.26. The firm has a market cap of $7.06 billion, a PE ratio of 27.13, a price-to-earnings-growth ratio of 2.05 and a beta of 0.51. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, topping the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The business had revenue of $673.25 million during the quarter, compared to analysts’ expectations of $665.04 million. During the same period in the prior year, the business earned $4.27 EPS. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Analysts expect that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. Chemed’s payout ratio is currently 14.06%.

Analysts Set New Price Targets

Several research firms have recently weighed in on CHE. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Royal Bank Of Canada raised their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 30th. Weiss Ratings upgraded shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Finally, Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $530.75.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the company’s stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the sale, the director directly owned 3,533 shares of the company’s stock, valued at $1,879,556. The trade was a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 6,537 shares of company stock valued at $3,406,014 in the last 90 days. Insiders own 3.33% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.